Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-08-19

Clinical Trial Update: Bempedoic Acid in PPCI Impact on Clinical Outcome and Inflammatory Markers

View source ↗

Summary

A trial evaluating whether bempedoic acid influences outcomes and inflammation in ST-elevation myocardial infarction patients treated with primary PCI; currentl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nexletol (bempedoic acid)

Snippet

Sponsor: Assiut University | Conditions: ST Elevation (STEMI) Myocardial Infarction | Status: NOT_YET_RECRUITING